How Should a Safe and Effective COVID‑19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton

Recently, there have been encouraging commitments around the world to manufacture coronavirus disease 2019 (COVID-19) vaccines in anticipation of results from clinical studies. Continue Reading

State of the Art Literature Reviews: Why They Fail

  Written by Susan Sykes, Director of Marketing & Communications, Evidence Partners If you’re involved in the preparation of Clinical Evaluation Reports (CERs) for medical devices, you’re likely to find yourself doing a lot more literature reviews in the near future.… Continue Reading